Winter 2022/2023 Vol. 12 Issue 04
-
From the Editor-in-Chief
Taking Aim at CancerTherapeutic antibodies carry ‘payloads’ to destroy cancer cells.
by William G. Nelson, MD, PhD
-
-
Your Cancer Guide
Finding Light in Winter’s DarknessColder temperatures, gray skies and shorter days can dampen the spirits, which can heighten sadness associated with cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Creating Calm in ChaosA prepacked bag of essential and not-so-essential items can provide structure and comfort to people with cancer during treatment.
by K.J. Bannan
-
Policy Matters
Stemming the E-Cigarette EpidemicAn updated AACR-ASCO joint statement recommends steps for policymakers to lower e-cigarette use among youth and young adults.
by Roy S. Herbst, MD, PhD
-
Cervical Cancer: A Global ChallengeLow- and middle-income countries make inroads against a preventable and treatable cancer.
by Erin O’Donnell
-
Mysterious MicrobesScientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
by Natalie Slivinski
-
An Ongoing DiscussionPhysicians are often hesitant to bring up end-of-life care discussions with their patients. People being treated for cancer may need to frame questions to determine their own goals of care.
by Cameron Walker
-
Survivor Profile
Rising to the ChallengeJames R. Scott uses his experiences with bladder cancer to be a light for others.
by Lindsey Konkel Neabore
-
-
Q&A
The FDA’s Risk-Benefit FrameworkUsing the withdrawal of Avastin’s approval for breast cancer as a case study, Mikkael A. Sekeres’ new book analyzes the U.S. drug approval process.
by Marci A. Landsmann
-
-
Get Involved
Healing Takes FlightAlicia and Esther Tambe honor their sister’s memory by providing travel experiences to Black women diagnosed with breast cancer.
by Thomas Celona
-
Facts and Stats
Setting the StageUnderstanding your cancer’s stage is important for determining your prognosis and treatment options. Here’s what the different stages mean.
by Thomas Celona
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
